{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,26]],"date-time":"2026-04-26T17:28:28Z","timestamp":1777224508520,"version":"3.51.4"},"reference-count":55,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2018,12,29]],"date-time":"2018-12-29T00:00:00Z","timestamp":1546041600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["ascpt.onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Clin Pharma and Therapeutics"],"published-print":{"date-parts":[[2019,1]]},"abstract":"<jats:p>Safe and effective lifelong treatment to control human immunodeficiency virus (<jats:styled-content style=\"fixed-case\">HIV<\/jats:styled-content>) infection is one of the greatest scientific and public health achievements of the past century. The majority of infected individuals able to maintain a daily oral regimen now have a normal or near\u2010normal life expectancy. More than 30 approved drugs and dozens of formulations have produced thousands of possible drug combinations used clinically in the past, but today most patients receive only a handful of high priority and rigorously tested regimens. Unique features of antiretroviral therapy include the need for lifelong treatment to control virus replication and the possibility of rapid emergence of permanent drug resistance if these agents are not properly used. Although three\u2010drug combination oral regimens have radically altered the course of this epidemic, the future will include long\u2010acting injectable and implantable drugs and devices to treat and prevent infection.<\/jats:p>","DOI":"10.1002\/cpt.1284","type":"journal-article","created":{"date-parts":[[2018,11,9]],"date-time":"2018-11-09T11:55:17Z","timestamp":1541764517000},"page":"61-70","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":20,"title":["Modern Human Immunodeficiency Virus Therapy: Progress and Prospects"],"prefix":"10.1111","volume":"105","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4495-5349","authenticated-orcid":false,"given":"Charles","family":"Flexner","sequence":"first","affiliation":[{"name":"Divisions of Clinical Pharmacology and Infectious Diseases Departments of Medicine, Pharmacology and Molecular Sciences, and International Health School of Medicine and Bloomberg School of Public Health Johns Hopkins University  Baltimore Maryland USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2018,12,29]]},"reference":[{"key":"e_1_2_11_1_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.0030442"},{"key":"e_1_2_11_2_1","unstructured":"Department of Health and Human Services (DHHS).Guidelines for the use of antiretroviral agents in HIV\u20101 infected adults and adolescents. <http:\/\/aidsinfo.nih.gov\/guidelines>. Last updated 30 May 2018."},{"key":"e_1_2_11_3_1","doi-asserted-by":"publisher","DOI":"10.7448\/IAS.20.01.21678"},{"key":"e_1_2_11_4_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.7824947"},{"key":"e_1_2_11_5_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.285.10.1308"},{"key":"e_1_2_11_6_1","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-117-6-487"},{"key":"e_1_2_11_7_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.82.20.7096"},{"key":"e_1_2_11_8_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198707233170401"},{"key":"e_1_2_11_9_1","doi-asserted-by":"publisher","DOI":"10.1038\/343470a0"},{"key":"e_1_2_11_10_1","doi-asserted-by":"publisher","DOI":"10.1038\/373117a0"},{"key":"e_1_2_11_11_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199804303381808"},{"key":"e_1_2_11_12_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.272.5265.1167"},{"key":"e_1_2_11_13_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(12)70134-2"},{"key":"e_1_2_11_14_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0910370"},{"key":"e_1_2_11_15_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1105243"},{"key":"e_1_2_11_16_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1011205"},{"key":"e_1_2_11_17_1","doi-asserted-by":"publisher","DOI":"10.2174\/1568005033481042"},{"key":"e_1_2_11_18_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa062360"},{"key":"e_1_2_11_19_1","unstructured":"World Health Organization.Updated recommendations on first\u2010line and second\u2010line antiretroviral regimens and post\u2010exposure prophylaxis and recommendations on early infant diagnosis of HIV: interim guidance. <http:\/\/www.who.int\/hiv\/pub\/guidelines\/ARV2018update\/en\/>. Last updated July 2018."},{"key":"e_1_2_11_20_1","doi-asserted-by":"publisher","DOI":"10.1097\/COH.0000000000000390"},{"key":"e_1_2_11_21_1","doi-asserted-by":"publisher","DOI":"10.1038\/nrd2336"},{"key":"e_1_2_11_22_1","doi-asserted-by":"publisher","DOI":"10.1097\/COH.0000000000000011"},{"key":"e_1_2_11_23_1","first-page":"1137","volume-title":"Goodman and Gilman's the Pharmacological Basis of Therapeutics","author":"Flexner C.","year":"2017"},{"key":"e_1_2_11_24_1","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciu221"},{"key":"e_1_2_11_25_1","doi-asserted-by":"publisher","DOI":"10.1097\/COH.0000000000000468"},{"key":"e_1_2_11_26_1","doi-asserted-by":"publisher","DOI":"10.1097\/QAI.0b013e318276cda9"},{"key":"e_1_2_11_27_1","doi-asserted-by":"publisher","DOI":"10.1097\/QAD.0000000000001845"},{"key":"e_1_2_11_28_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMc1807653"},{"key":"e_1_2_11_29_1","unstructured":"U.S Food and Drug Administration.FDA Drug Safety Podcast: FDA to evaluate potential risk of neural tube birth defects with HIV medicine dolutegravir(Juluca Tivicay Triumeq). <https:\/\/www.fda.gov\/Drugs\/DrugSafety\/ucm608708.htm>. Last updated 24 May 2018."},{"key":"e_1_2_11_30_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1711460"},{"key":"e_1_2_11_31_1","doi-asserted-by":"publisher","DOI":"10.1086\/652190"},{"key":"e_1_2_11_32_1","doi-asserted-by":"publisher","DOI":"10.1097\/COH.0000000000000374"},{"issue":"5","key":"e_1_2_11_33_1","first-page":"1","article-title":"Behavioral and clinical characteristics of persons receiving medical care for HIV infection \u2013 Medical Monitoring Project, United States, 2009","volume":"63","author":"Blair J.M.","year":"2014","journal-title":"MMWR Suppl."},{"key":"e_1_2_11_34_1","doi-asserted-by":"publisher","DOI":"10.2217\/nnm.12.214"},{"key":"e_1_2_11_35_1","article-title":"Interest of youth living with HIV in long\u2010acting antiretrovirals","author":"Weld E.D.","journal-title":"J. Acquir. Immune Defic. Syndr."},{"key":"e_1_2_11_36_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(17)31917-7"},{"key":"e_1_2_11_37_1","doi-asserted-by":"publisher","DOI":"10.1038\/clpt.2014.118"},{"key":"e_1_2_11_38_1","doi-asserted-by":"publisher","DOI":"10.1310\/hct1405-192"},{"key":"e_1_2_11_39_1","doi-asserted-by":"publisher","DOI":"10.1097\/COH.0000000000000480"},{"key":"e_1_2_11_40_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(15)00152-8"},{"key":"e_1_2_11_41_1","doi-asserted-by":"publisher","DOI":"10.1097\/COH.0000000000000475"},{"key":"e_1_2_11_42_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1002493"},{"key":"e_1_2_11_43_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1608243"},{"key":"e_1_2_11_44_1","doi-asserted-by":"publisher","DOI":"10.1038\/nature18929"},{"key":"e_1_2_11_45_1","first-page":"289","article-title":"Antiretroviral implants for treatment and prevention of HIV infection","volume":"13","author":"Flexner C.","year":"2018","journal-title":"Curr. Opin. HIV\/AIDS"},{"key":"e_1_2_11_46_1","doi-asserted-by":"publisher","DOI":"10.1097\/COH.0000000000000467"},{"key":"e_1_2_11_47_1","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01058-18"},{"key":"e_1_2_11_48_1","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00656-15"},{"key":"e_1_2_11_49_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2018.1917"},{"key":"e_1_2_11_50_1","doi-asserted-by":"publisher","DOI":"10.1097\/QAD.0000000000001478"},{"key":"e_1_2_11_51_1","doi-asserted-by":"publisher","DOI":"10.1097\/QAD.0000000000001401"},{"key":"e_1_2_11_52_1","doi-asserted-by":"publisher","DOI":"10.4081\/idr.2016.6570"},{"key":"e_1_2_11_53_1","doi-asserted-by":"publisher","DOI":"10.1097\/COH.0000000000000376"},{"key":"e_1_2_11_54_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2011.12.116"},{"key":"e_1_2_11_55_1","unstructured":"National Institutes of Health.FDA approval of HIV medicines. <https:\/\/aidsinfo.nih.gov\/understanding-hiv-aids\/infographics\/25\/fda-approval-of-hiv-medicines>. Accessed 24 October 2018."}],"container-title":["Clinical Pharmacology &amp; Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fcpt.1284","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/cpt.1284","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1002\/cpt.1284","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/ascpt.onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/cpt.1284","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,7]],"date-time":"2023-11-07T13:35:52Z","timestamp":1699364152000},"score":1,"resource":{"primary":{"URL":"https:\/\/ascpt.onlinelibrary.wiley.com\/doi\/10.1002\/cpt.1284"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,12,29]]},"references-count":55,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,1]]}},"alternative-id":["10.1002\/cpt.1284"],"URL":"https:\/\/doi.org\/10.1002\/cpt.1284","archive":["Portico"],"relation":{},"ISSN":["0009-9236","1532-6535"],"issn-type":[{"value":"0009-9236","type":"print"},{"value":"1532-6535","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,12,29]]},"assertion":[{"value":"2018-09-07","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2018-10-31","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2018-12-29","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}